Multiple sclerosis: The increased frequency of the ICAM-1 exon 6 gene point mutation genetic type K469

Annals of Neurology

Volumn 44, Issue 1, 1998, Pages 70-75

  Mycko, Marcin P ^a   Kwinkowski, Marek ^a   Tronczynska, Ewa ^a   Szymanska, Bozena ^a   Selmaj, Krzysztof W ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1;

ALLERGIC ENCEPHALOMYELITIS; ARTICLE; CELL ADHESION; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HUMAN; HUMAN CELL; LIGAND BINDING; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; POINT MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

BASE SEQUENCE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DNA; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC SCREENING; GENOTYPE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LINKAGE (GENETICS); MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; POINT MUTATION; POLYMORPHISM, GENETIC; RANDOM ALLOCATION; REFERENCE VALUES;

EID: 0031947049     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440113     Document Type: Article

References (38)

1. Liblau RS, Singer SM, McDevitt HO. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995;16:34-48
2. Hart MN, Fabry Z. CNS presentation. Trends Neurosci 1995; 18:475-481
3. Selmaj K. Pathophysiology of the blood-brain barrier. Springer Semin Immunopathol 1996;18:57-73
4. Kuchroo VK, Martin CA, Greee JM, et al. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J Immunol 1993;151:4371-4382
5. Baron JL, Madri JA, Ruddle NH, et al. Surface expression of a4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med 1993;177:57-68
6. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994;84:2068-2101
7. Rossiter H, Alon R, Kupper TS. Selectins, T-cell rolling and inflammation. Mol Med Today 1997;5:214-222
8. Imhof BA, Dunon D. Leukocyte migration and adhesion. Adv Immunol 1995;58:345-416
9. Chapman PT, Haskard DO. Leukocyte adhesion molecules. Br Med Bull 1995;51:296-311
10. Raine CS, Cannella B. Adhesion molecules and central nervous system inflammation. Semin Neurosci 1992;4:201-219
11. Dustin ML, Rithlein R, Bhan AK, et al. Induction by IL-1 and interferon-g: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-I). J Immunol 1986;137: 245-254
12. Myers CL, Wertheimer SJ, Schembri KJ, et al. Introduction of ICAM-1 by TNF-alpha, IL1-beta, and LPS in human endothelial cells after downregulation of PKC. Am J Physiol 1992;263: C767-C772
13. Raine CS. Multiple sclerosis: TNF revisited, with promise. Nat Med 1995;1:244-248
14. Probert L, Selmaj K. TNF and related molecules: trends in neuroscience and clinical applications. J Neuroimmunol 1997;72: 113-117
15. Washington R, Burton J, Todd RF III, et al. Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis. Ann Neurol 1994;35:89-97
16. Sharief MK, Noori MA, Cardi M, et al. Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage. J Neuroimmunol 1993;43:15-21
17. Rieckmann P, Martin S, Weichselbraun I, et al. Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapse. Neurology 1994;44:2367-2372
18. Archelos JJ, Jung S, Maurer M, et al. Inhibition of experimental autoimmune encephalomyelitis by an antibody to intercellular adhesion molecule ICAM-1. Ann Neurol 1993;34:145-154
19. Tsukada N, Matsuda M, Miyagi K, Yanagisawa N. In vitro intercellular adhesion molecule-1 expression on brain endothelial cells in multiple sclerosis. J Neuroimmunol 1994;49:181-187
20. Ebers GC. Genetics and multiple sclerosis: an overview. Ann Neurol 1994;36(Suppl):S12-S14
21. Ebers GC, Sadovnick AD. The role of genetic factors in multiple sclerosis susceptibility. J Neuroimmunol 1994;54:1-17
22. Hillert J. Human leukocyte antigen studies in multiple sclerosis. Ann Neurol 1994;36(Suppl):S15-S17
23. Sawcer S, Jones HB, Feakes R, et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 1996;13:464-468
24. The Multiple Sclerosis Generics Group. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat Genet 1996;13:469-471
25. Ebers GC, Kukay K, Bulman DE, et al. A full genome search in multiple sclerosis. Nat Genet 1996;13:472-476
26. Kuokkanen S, Sundvall M, Terwillinger JD, et al. A putative vulnerability locus to multiple sclerosis maps to 5p14-5p12 in a region syntenic to the murine locus Eae2. Nat Genet 1996; 13:477-480
27. Vora DK, Rosenbloom CR, Beaudet AL, Cottingham RW. Polymorphism and linkage analysis for ICAM-1 and the selectin gene cluster. Genomics 1994;21:473-477
28. Diamond MS, Staunton DE, Marlin SD, Springer TA. Binding of the integrin Mac-1 (CD11b/CD 18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 1991;65:961-971
29. Poser CM, Paty DW, Scheinberg L, et al. New diagnostics criteria for multiple sclerosis - guidelines for research protocols. Ann Neurol 1983;13:227-231
30. Gustincich S, Manfiolett G, Del Sal G, et al. A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques 1991;11:298-302
31. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33: 1444-1452
32. Trask B, Fertitta A, Christensen M, et al. Fluorescence in situ hybridization mapping of human chromosome 19: cytogenetic band location of 540 cosmids and 70 genes for DNA markers. Genomics 1993;15:133-140
33. Kirchhausen T, Staunton DE, Springer TA. Location of the domains of ICAM-1 by immunolabeling and single-molecule electron microscopy. J Leukoc Biol 1993;53:342-346
34. van de Stolpe A, van der Saag PT. Intercellular adhesion molecule-1. J Mol Med 1996;74:13-33
35. Staunton DE, Dustin ML, Erickson HP, Springer TA. The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus. Cell 1990;61: 243-254
36. Lineberger DW, Uncapher CR, Graham DJ, Colonno RJ. Domains 1 and 2 of ICAM-1 are sufficient to bind human rhinoviruses. Virus Res 1992;24:173-186
37. Joling P, Boom S, Johnson J, et al. Domain 5 of the intercellular adhesion molecule-1 (ICAM-1) is involved in adhesion of B-cells and follicular dendritic cells. Adv Exp Med Biol 1994; 355:131-135
38. Molgg M, Schwaeble W, Johnson JP, Dierich MP. Generation of recombinant, carbohydrate-free intercellular adhesion molecule-1 (ICAM-1) and ICAM-1 fragments in Escherichia coli and mapping of epitopes recognized by anti-ICAM-1 monoclonal antibodies. Immunol Lett 1991;8:237-243